Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Moreillon

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Schweizerische Medizinische Wochenschrift|December 24, 1983
[Endarterial infections, redoubtable complications of non-typhi salmonella infections]P Moreillon, P Francioli, F Delacrétaz, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1996
Efficacy of clarithromycin versus that of clindamycin for single-dose prophylaxis of experimental streptococcal endocarditisD Vermot, J M Entenza, J Vouillamoz, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 18, 2001
Breakthrough Streptococcus pneumoniae meningitis during clarithromycin therapy for acute otitis mediaP Y Bochud, T Calandra, P Moreillon, et al.
Schweizerische Medizinische Wochenschrift|February 23, 1985
[Prevalence of infectious diseases at the Vaud University Hospital Center]P Moreillon, P E Broquet, J Bille, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2010
Failure of vancomycin continuous infusion against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureusJ M Entenza, T R Veloso, J Vouillamoz, et al.
The Journal of Infectious Diseases|January 1, 1997
Importance of genotypic and phenotypic tolerance in the treatment of experimental endocarditis due to Streptococcus gordoniiJ M Entenza, I Caldelari, M P Glauser, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2000
Quinupristin-dalfopristin combined with beta-lactams for treatment of experimental endocarditis due to Staphylococcus aureus constitutively resistant to macrolide-lincosamide-streptogramin B antibioticsJ Vouillamoz, J M Entenza, C Féger, et al.
The Journal of Infectious Diseases|May 1, 1988
Predictors of endocarditis in isolates from cultures of blood following dental extractions in rats with periodontal diseaseP Moreillon, C D Overholser, R Malinverni, et al.
Infection and Immunity|June 24, 2003
Teichoic acids are not required for Streptococcus pneumoniae and Staphylococcus aureus cell walls to trigger the release of tumor necrosis factor by peripheral blood monocytesP A Majcherczyk, E Rubli, D Heumann, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2001
Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistanceJ M Entenza, Y A Que, J Vouillamoz, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Schweizerische Medizinische Wochenschrift|December 24, 1983
[Endarterial infections, redoubtable complications of non-typhi salmonella infections]P Moreillon, P Francioli, F Delacrétaz, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1996
Efficacy of clarithromycin versus that of clindamycin for single-dose prophylaxis of experimental streptococcal endocarditisD Vermot, J M Entenza, J Vouillamoz, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 18, 2001
Breakthrough Streptococcus pneumoniae meningitis during clarithromycin therapy for acute otitis mediaP Y Bochud, T Calandra, P Moreillon, et al.
Schweizerische Medizinische Wochenschrift|February 23, 1985
[Prevalence of infectious diseases at the Vaud University Hospital Center]P Moreillon, P E Broquet, J Bille, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2010
Failure of vancomycin continuous infusion against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureusJ M Entenza, T R Veloso, J Vouillamoz, et al.
The Journal of Infectious Diseases|January 1, 1997
Importance of genotypic and phenotypic tolerance in the treatment of experimental endocarditis due to Streptococcus gordoniiJ M Entenza, I Caldelari, M P Glauser, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2000
Quinupristin-dalfopristin combined with beta-lactams for treatment of experimental endocarditis due to Staphylococcus aureus constitutively resistant to macrolide-lincosamide-streptogramin B antibioticsJ Vouillamoz, J M Entenza, C Féger, et al.
The Journal of Infectious Diseases|May 1, 1988
Predictors of endocarditis in isolates from cultures of blood following dental extractions in rats with periodontal diseaseP Moreillon, C D Overholser, R Malinverni, et al.
Infection and Immunity|June 24, 2003
Teichoic acids are not required for Streptococcus pneumoniae and Staphylococcus aureus cell walls to trigger the release of tumor necrosis factor by peripheral blood monocytesP A Majcherczyk, E Rubli, D Heumann, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2001
Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistanceJ M Entenza, Y A Que, J Vouillamoz, et al.
Pageof 8